Holly Tao is a litigation associate in the New York office and a member of the Firm's Global Antitrust/Competition Group. Her practice focuses on complex litigation in the areas of antitrust, patent, and commercial contractual disputes.
She has represented global pharmaceutical companies in state and federal courts. Her experience includes litigation arising under the Biologics Price Competition and Innovation Act and the Hatch-Waxman Act, as well as nationwide class-action litigations at the cutting edge of antitrust and intellectual property. Her practice also includes counseling clients on antitrust, patent, and intellectual property risk issues.
Holly is active in the Firm's pro bono work. She represents individuals and organizations at both trial and appellate courts, and has litigated matters regarding US constitutional rights as well as cases brought under Title VII of the Civil Rights Act and the Individuals with Disabilities Education Act.
